Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 P&G, Sanofi-Aventis File Osteo Suit Against Roche, GSK | Contract Pharma

What are you searching for?

Sign in
Breaking News

P&G, Sanofi-Aventis File Osteo Suit Against Roche, GSK

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Procter & Gamble Pharmaceuticals and Sanofi-Aventis U.S. LLC, a member of the Sanofi-Aventis Group, co-marketers of Actonel, filed a lawsuit under the Lanham Act against Roche and GlaxoSmithKline in the U.S. Federal District Court of NY. The lawsuit alleges that Roche and GSK engaged in false and misleading advertising regarding their prescription osteoporosis medication, Boniva tablets. The lawsuit seeks an injunction to stop that advertising.

The lawsuit specifically alleges that advertising for Boniva falsely claims that the drug has been proven to reduce the risk of nonspinal fractures, and that the drug has demonstrated efficacy against nonspinal fracture comparable to other bisphosphonates, such as Actonel. Claims appear in advertising directed at both consumers and physicians, according to the suit. The complaint further alleges that the Boniva label and clinical study data do not support these claims.

Both Actonel and Boniva have been proven to reduce the risk of spinal fractures at three years in women with postmenopausal osteoporosis. However, Boniva has not been proven to reduce the risk of nonspinal fracture whereas Actonel has been proven to reduce the risk of nonspinal fractures at three years, according to a P&G/SA statement. Because they are less common individually than spinal fractures, nonvertebral fractures were measured as a group that included the wrist, hip, pelvis, femur, forearm and collarbone.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters